Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study

Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study

We aimed to assess the efficacy of biologic therapy in refractory non-Multiple Sclerosis (MS) Optic Neuritis (ON), a condition more infrequent, chronic and severe than MS ON. This was an open-label multicenter study of patients with non-MS ON refractory to systemic corticosteroids and at least one c...

Full description

Bibliographic Details
Main Authors: Alba Herrero-Morant, Carmen Álvarez-Reguera, José L. Martín-Varillas, Vanesa Calvo-Río, Alfonso Casado, Diana Prieto-Peña, Belén Atienza-Mateo, Olga Maiz-Alonso, Ana Blanco, Esther Vicente, Íñigo Rúa-Figueroa, Laura Cáceres-Martin, José L. García-Serrano, José Luis Callejas-Rubio, Norberto Ortego-Centeno, Javier Narváez, Susana Romero-Yuste, Julio Sánchez, Paula Estrada, Rosalía Demetrio-Pablo, David Martínez-López, Santos Castañeda, José L. Hernández, Miguel Á. González-Gay, Ricardo Blanco
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Journal of Clinical Medicine
Subjects:
optic neuritis
biologic therapy
rituximab
tocilizumab
adalimumab
infliximab
Online Access:https://www.mdpi.com/2077-0383/9/8/2608

Internet

https://www.mdpi.com/2077-0383/9/8/2608

Similar Items